Research Article
Role of Annexin A1 in Squamous Cell Lung Cancer Progression
Table 2
Immunohistochemistry analysis of SQCLC patient samples.
| Features | Cases | ANXA1 | value | — | + |
| Gender | | | | | Male | 63 | 50 (79.4%) | 13 (20.6%) | 0.359 | Female | 18 | 16 (88.9%) | 2 (11.1%) | Age | | | | | ≥60 | 59 | 50 (84.7%) | 9 (15.3%) | 0.2155 | <60 | 22 | 16 (72.7%) | 6 (27.3%) | Lymph node metastasis | | | | | Yes | 37 | 30 (81.1%) | 7 (18.9%) | 0.9322 | No | 44 | 36 (81.8%) | 8 (18.2%) | Degree of differentiation | | | | | I+II | 64 | 52 (81.3%) | 12 (18.8%) | 0.9171 | III | 17 | 14 (82.4%) | 3 (17.6%) | Clinical stage | | | | | I+II | 56 | 46 (82.1%) | 10 (17.9%) | 0.8978 | III+IV | 24 | 20 (83.3%) | 4 (16.7%) |
|
|
SQCLC: squamous cell lung cancer, values are calculated according to Chi-square test. |